Craig Wheeler

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) fell nearly 4 percent Thursday to $63.34 following news that the FDA denied its petition to block generic versions of its Copaxone drug. Mylan NV (NASDAQ: MYL) surged amid the news to $67.76, up 1.48 percent, while Momenta Pharmaceuticals,...